Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
12 2019
Historique:
received: 01 02 2019
accepted: 29 05 2019
pubmed: 14 8 2019
medline: 1 7 2020
entrez: 14 8 2019
Statut: ppublish

Résumé

Heart failure remains a major source of late morbidity and mortality after myocardial infarction (MI). The temporospatial presence of activated fibroblasts in the injured myocardium predicts the quality of cardiac remodeling after MI. Therefore, monitoring of activated fibroblasts is of great interest for studying cardiac remodeling after MI. Fibroblast activation protein (FAP) expression is upregulated in activated fibroblasts. This study investigated the feasibility of imaging activated fibroblasts with a new

Identifiants

pubmed: 31405922
pii: jnumed.119.226993
doi: 10.2967/jnumed.119.226993
pmc: PMC6894377
doi:

Substances chimiques

68Ga-FAPI 0
Gallium Radioisotopes 0
Membrane Proteins 0
Quinolines 0
Gallium-68 98B30EPP5S

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1743-1749

Informations de copyright

© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Trends Mol Med. 2016 Feb;22(2):99-114
pubmed: 26776094
Am J Pathol. 2004 Jul;165(1):247-58
pubmed: 15215180
JACC Heart Fail. 2018 Mar;6(3):179-186
pubmed: 29496021
Nature. 2008 Dec 18;456(7224):980-4
pubmed: 19043405
Cell Tissue Res. 2016 Sep;365(3):563-81
pubmed: 27324127
J Nucl Med. 2018 Sep;59(9):1415-1422
pubmed: 29626119
J Nucl Cardiol. 2010 Dec;17(6):1065-72
pubmed: 20658273
J Mol Cell Cardiol. 2015 Oct;87:194-203
pubmed: 26319660
J Nucl Med. 2018 Sep;59(9):1423-1429
pubmed: 29626120
JACC Cardiovasc Imaging. 2009 Feb;2(2):187-98
pubmed: 19356555
J Am Coll Cardiol. 2008 Dec 9;52(24):2017-28
pubmed: 19055994
Proc Natl Acad Sci U S A. 1990 Sep;87(18):7235-9
pubmed: 2402505
Heart. 2017 Apr;103(8):607-615
pubmed: 27927700
J Clin Invest. 2004 Jun;113(12):1684-91
pubmed: 15199403
Am J Physiol Heart Circ Physiol. 2018 Sep 1;315(3):H563-H570
pubmed: 29949382
Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H146-53
pubmed: 16113078
J Card Fail. 2006 Jun;12(5):399-405
pubmed: 16762804
Cardiovasc Res. 2011 Feb 1;89(2):265-72
pubmed: 20880837
Proc Natl Acad Sci U S A. 2017 May 2;114(18):4679-4684
pubmed: 28416697
J Clin Invest. 2013 Jan;123(1):92-100
pubmed: 23281415
Science. 1994 Apr 22;264(5158):569-71
pubmed: 7512751
Nat Rev Cardiol. 2010 Jan;7(1):30-7
pubmed: 19949426
Ann N Y Acad Sci. 2012 Apr;1254:33-41
pubmed: 22548567
Circ Res. 2014 Feb 28;114(5):903-15
pubmed: 24577969
J Invest Dermatol. 2012 Nov;132(11):2565-72
pubmed: 22696053
ACS Med Chem Lett. 2013 Mar 18;4(5):491-6
pubmed: 24900696
J Immunol. 2005 Dec 1;175(11):7708-18
pubmed: 16301681

Auteurs

Zohreh Varasteh (Z)

Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany zohreh.varasteh@tum.de.

Sarajo Mohanta (S)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany.
German Centre for Cardiovascular Research, Munich Heart Alliance, Munich, Germany; and.

Stephanie Robu (S)

Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany.

Miriam Braeuer (M)

Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany.

Yuanfang Li (Y)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany.

Negar Omidvari (N)

Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany.

Geoffrey Topping (G)

Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany.

Ting Sun (T)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany.

Stephan G Nekolla (SG)

Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany.

Antonia Richter (A)

Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany.

Christian Weber (C)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany.
German Centre for Cardiovascular Research, Munich Heart Alliance, Munich, Germany; and.

Andreas Habenicht (A)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany.

Uwe A Haberkorn (UA)

Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany.

Wolfgang A Weber (WA)

Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH